Onyx Scientific opens second site

CDMO Onyx Scientific has opened a second facility at its headquarters site in Sunderland, UK.This doubles its footprint and allows for expansion of all CMC activities, including additional GMP facilities that increases capacity for GMP and commercial API manufacturing capacity by 50%.

The first phase is now operational with GMP certification and approval from the UK MHRA for commercial manufacturing and the final two should be complete by the end of 2022. Growing demand has seen Onyx increase its workforce by 40% to 100 in the 2021-2 financial year and it expects a further 50% increase in the next three.